- Symbol
- DNLI
- Segment MIC
- XNGS
- ISIN
- US24823R1059
- Trading currency
- USD
XNGS:DNLI — listed on NASDAQ GLOBAL SELECT MARKET
Denali Therapeutics Inc. discovers, develops, and delivers biotherapeutics aimed at treating serious diseases, particularly those affecting the brain and body. The company utilizes its proprietary TransportVehicle™ platform to create barrier-crossing therapeutics, focusing on neurodegenerative diseases and lysosomal storage disorders. Denali's pipeline includes a range of investigational therapies designed to address these conditions, with an emphasis on collaboration with the patient community to inform its research and development efforts.